[2P-0005] Signaling pathway of histone deacetylase inhibitor (HDI) ~Development of Adverse Outcome Pathway (AOP) in OECD~
signaling pathway, Adverse Outcome Pathway, OECD, histone deacetylase inhibitor
This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.